Raiseby Fusion42
Open the live dashboard →

Drug Discovery: venture funds and startups

Fusion42 tracks 45 venture funds in Drug Discovery with $15.2B in combined assets under management, and 3 startups that have raised $26M between them. The data below is live from the same database that powers Raise and Scout, and is continuously enriched as new rounds and funds are announced.

Part of the Raise fund database and the Scout startup database by Fusion42 — the same live data Arthur, Fusion42's AI co-founder, reasons over.

active funds in Drug Discovery include AlleyCorp Fund II, Criteria Bio Ventures, Yosemite Fund II, Bertelsmann Healthcare Investments and Genesys University Seed Fund; startups in Drug Discovery include Waypoint Bio, SwishX and Thalia Therapeutics. Each name links through to a full machine-readable profile — its backers, rounds and related Wire analysis — and the tables below list every entity Fusion42 tracks in Drug Discovery, refreshed as new rounds and funds are announced.

Funds in Drug Discovery (45 tracked)

FundTypeHQ
AlleyCorp Fund IIvcUnited States
Criteria Bio VenturesvcSpain
Yosemite Fund IIvcUnited States
Bertelsmann Healthcare Investmentscorporate vcGermany
Genesys University Seed FundvcCanada
Elanco Venturescorporate vcUnited States
Kos Biotechnology FundvcGreece
Star51 CapitalvcUnited States
Lotte Healthcare and Biopharmaceutical CVCcorporate vcJapan
BOLDcorporate vcFrance
Asabys Innvierte Tech TransfervcSpain
YosemitevcUnited States
Montana Children's HealthvcSpain
Cancer Breakthrough FundvcCanada
Servier Venturescorporate vcFrance
WorldQuant GenesisvcIsrael
AI Health FundvcUnited States
Northern GritstonevcUK
Spain–Boston Biotechnology initiativevcSpain
Life Sciences Venture FundvcCanada
Immune Boost CapitalvcUnited States
Toho-GB Global Life Science Fundcorporate vcJapan
Medicxi VvcUK
Sofinnova Capital XIvcFrance
ASA FundvcJapan
ArchvcUSA
UTokyo IPC Fund 2vcJapan
Lupus VenturesvcUnited States
Boehringer Ingelheim Venture Fundcorporate vcGermany
PxB FundvcUS
T1D FundvcUSA
Crossroads Health VenturesvcUnited States
Epidarex Capital IVvcUK
LifeArc Venturescorporate vcUK
Blue FundvcFrance
InceptionBiovcSpain
Breakout VenturesvcUnited States
Braidwell Partners FundvcUnited States
New Jersey Innovation Evergreen FundvcUnited States
Dimensionvc
Celiac Disease Foundation Impact FundvcUnited States
UBC Catalyst Venture FundvcCanada
Santé Ventures Fund 5vcUnited States
Sofinnova PartnersvcFrance
Bow River Evergreen Venture CapitalvcUnited States

Startups in Drug Discovery (3 tracked)

StartupStageHQRaised
Waypoint Bioseries-aUnited States$20M
SwishXseedIndia$2M
Thalia TherapeuticsUnited Kingdom$3M

Recent Wire analysis

StoryPublished
Bora inks $2.5B deal with drug discovery AI specialist Insilico16 July 2026
Checkpoint Inhibitors Are Failing Recurrent GBM. This Phase 1 Trial Design May Explain ...12 July 2026
Bexobrutideg Could Pave the Way for BTK Degraders in R/R Chronic Lymphocytic Leukemia8 July 2026
Aureka Launches Free AI Drug Discovery Model8 July 2026